Agricultural markets saw continued pressure in lean hog futures during Thursday's session, extending a recent downward trend. Contracts fell by 77 cents to settle at $1.50 by midday. The decline coincided with a USDA report showing the national base hog price at $92.16, a decrease of 89 cents from the previous day. While the CME Lean Hog Index posted a modest gain to $91.20 as of March 10, weekly export sales presented a mixed picture.
Contrasting Pork Trade Data
USDA figures revealed weekly export sales for pork hit a yearly low of 23,723 metric tons. However, actual shipments during the same period increased to 38,897 MT. In a brighter note for the sector, monthly pork exports reached a five-year high of 590 million pounds in January. The pork carcass cutout value rose by 24 cents to $98.65 per hundredweight, though specific cuts like butt and ham experienced declines. Federally inspected hog slaughter totaled nearly 1.5 million head last week, showing an increase from prior periods. Futures contracts for April through June all moved lower, signaling persistent market pressure on hog prices.
Indian Equities Plunge on Multiple Headwinds
Across global markets, Indian stocks faced a severe selloff. The benchmark BSE Sensex plummeted over 600 points, with the NSE Nifty falling nearly 1%. The Sensex closed 708 points lower at 75,326, while the Nifty slumped 222 points to 23,417. Heavy selling was concentrated in banking, metal, and infrastructure stocks. Major decliners included HDFC Bank, ICICI Bank, Larsen & Toubro, and Tata Steel.
Market experts attributed the sharp decline to a confluence of factors. Geopolitical tensions in West Asia and the subsequent surge in crude oil prices above $100.5 per barrel for Brent crude significantly dampened investor sentiment. The closure of the Strait of Hormuz further constrained global oil supply, adding to inflationary worries.
Foreign Outflows and Sectoral Performance
Sustained selling by foreign portfolio investors was a key driver. Data showed foreign investors sold shares worth Rs 7,049 crore, only partially offset by domestic institutional purchases of Rs 7,449 crore. Sector-wide declines were noted across auto, FMCG, IT, metal, and private banking stocks on the National Stock Exchange. In contrast, pharmaceutical stocks demonstrated resilience, benefiting from currency depreciation and fewer external headwinds. Notable gainers amidst the downturn included Power Grid and Hindustan Unilever.
Dr. VK Vijayakumar, a noted market expert, cited global uncertainties and ongoing foreign investor selling as primary causes for the volatility. He advised investors to maintain patience and continue systematic investment approaches during such turbulent periods.
Earnings and Other Market Movers
In corporate earnings, Afya Limited reported fourth-quarter earnings of $0.41 per share, surpassing the Zacks Consensus Estimate of $0.38. This represented a 7.90% earnings surprise. Revenue for the quarter reached $169.03 million, though it slightly missed estimates by 4.57%. Despite a nearly 10% stock decline year-to-date, Afya maintains a Zacks Rank #2 (Buy), indicating an expected market outperformance. Consensus estimates project $0.54 EPS and $192.58 million in revenue for the upcoming quarter.
Elsewhere, Clarivate's share price surged 25.7% over the past month, though it remains down 20.1% year-to-date. A Discounted Cash Flow analysis suggested an intrinsic value of $6.76 per share, implying the stock could be undervalued by 61.7%. Its price-to-sales ratio of 0.68 sits below the professional services sector average.
In the bond market, the Franklin Canadian Short Term Bond Fund showed neutral ratings across all time horizons. AI-generated trading signals suggested a buy near CA$19.32 with a target of CA$19.41, and a short position near CA$19.41 targeting CA$19.32.
Operational concerns arose for Lloyds Banking Group following a reported data breach affecting users of its Bank of Scotland, Lloyds, and Halifax mobile apps, where some customers briefly viewed others' transaction details. The group is investigating the cause as regulators seek clarification, highlighting potential operational and regulatory risks.
